B1k chain of laminin and methods of use
CA 2467757 A1 · Owner: The State Of Oregon Acting By And Through The State Board Of Higher Educ Ation On Behalf Of Oregon Health Sciences University · Inventors: Burgeson, Robert E.; Wagman, David Wolfe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Recombinant laminin B1k and fragments thereof are produced. The recombinant laminin B1k is a subunit of kalinin a basement membrane protein useful for promoting adhesion of keratinocytes to a substrate and treatment of disorders of the dermis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 26, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 26, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 26, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.